Skip to main content

Aneurysm, Brain

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
1 program
MicrosurgeryN/A
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
MicrosurgeryN/A1 trial
Active Trials
NCT04819074Unknown4,000Est. Oct 2022
Penumbra
PenumbraALAMEDA, CA
1 program
WAVE, as part of the SMART COIL SystemN/A1 trial
Active Trials
NCT04106583Completed572Est. Aug 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsMicrosurgery
PenumbraWAVE, as part of the SMART COIL System

Clinical Trials (2)

Total enrollment: 4,572 patients across 2 trials

Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms

Start: May 2021Est. completion: Oct 20224,000 patients
N/AUnknown
NCT04106583PenumbraWAVE, as part of the SMART COIL System

Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities

Start: Nov 2019Est. completion: Aug 2023572 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.